FFUND congratulates Resistell AG on securing CHF 2M additional funding from the Swiss Start-up Innovation Project, financed by InnoSuisse. With this support, the company will accelerate the development of its disruptive nanomotion technology, designed to revolutionize diagnostics of infectious diseases.
About Resistell AG
Swiss medtech pioneer Resistell AG is tackling one of today’s most pressing global health threats: antimicrobial resistance (AMR). Their mission is to dramatically improve the speed and precision of antibiotic treatment decisions. With its groundbreaking technology, Resistell aims to save lives and fight the spread of resistant infections.
What is the product about?
Sepsi-Star is an innovative, next-generation phenotypic antibiotic susceptibility testing (AST) platform that provides actionable results in 1-2 hours. The platform is based on nanomotion sensing technology invented by Resistell’s team at EPFL Lausanne, one of the world’s top technical universities.
Sepsi-Star detects bacterial responses to antibiotics without the need for traditional culture steps. This enables clinicians to rapidly tailor antibiotic therapy and reduce the time to effective treatment. The solution not only improves patient outcomes but also supports global efforts to curb AMR and lower healthcare costs.
How did FFUND help?
Filipa Carvalhal (Project Lead) and Harita Yedavally (support and long-time collaborator of Resistell at FFUND): “The Resistell team is a true joy to work with – enthusiastic, full of ideas, and always making collaboration easy and effective. We strongly believe in the impact that Sepsi-Star can have on the future of infectious disease management. It was a real pleasure to help shape a winning proposal to support this exciting innovation on its path to clinical use.”
Danuta Cichocka (CEO of Resistell AG): “The FFUND team brings clarity and structure exactly when it’s needed most. They’re easy to work with and truly committed to getting things right.”
Greg Gonciarz (COO of Resistell AG): “Working with the FFUND team makes the whole process so much smoother! They’re sharp, reliable and really know their stuff.”
About Innosuisse
Innosuisse is the Swiss Innovation Agency that supports science-based start-ups with significant innovation potential. The Start-up Innovation Projects program helps early-stage companies bridge the gap between research and market entry. Unlike other programs, only the start-up itself is funded — not research partners.
